Precigen (PGEN) Director Jeffrey Kindler Sells 185,000 Shares
gurufocus.com · 2026-08-29
Director Jeffrey Kindler sold 185,000 shares of Precigen Inc (PGEN) on August 26, 2026, according to a recent SEC Filing. Following this transaction, the inside
TickrTrends take: Director Jeffrey Kindler's sale of 185,000 shares represents a significant insider transaction at Precigen, a Healthcare sector company currently awaiting full valuation assessment from TickrTrends. Large insider share dispositions can provide important signals about management's confidence in near-term prospects, making such transactions particularly relevant for investors evaluating the company's true valuation range. As TickrTrends works toward establishing comprehensive valuation metrics for PGEN, tracking patterns of insider buying and selling activity may help contextualize what company leadership believes about future value creation.
Read the full story at gurufocus.com →
Is PGEN undervalued? See TickrTrends' fair value analysis →